These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25742746)

  • 21. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.
    Nguyen PH; Giraud J; Staedel C; Chambonnier L; Dubus P; Chevret E; Bœuf H; Gauthereau X; Rousseau B; Fevre M; Soubeyran I; Belleannée G; Evrard S; Collet D; Mégraud F; Varon C
    Oncogene; 2016 Oct; 35(43):5619-5628. PubMed ID: 27157616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells.
    Soehngen E; Schaefer A; Koeritzer J; Huelsmeyer V; Zimmer C; Ringel F; Gempt J; Schlegel J
    Brain Tumor Pathol; 2014 Oct; 31(4):247-56. PubMed ID: 24197864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
    Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
    Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.
    Liu M; Inoue K; Leng T; Guo S; Xiong ZG
    Cell Signal; 2014 Dec; 26(12):2773-81. PubMed ID: 25192910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokeratin 19
    Saha SK; Kim K; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic roles of circulating ALDH1
    Tian S; Xing YN; Xia P
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30305380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.
    Madjd Z; Ramezani B; Molanae S; Asadi-Lari M
    Asian Pac J Cancer Prev; 2012; 13(6):2973-8. PubMed ID: 22938492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.
    Wang YC; Yo YT; Lee HY; Liao YP; Chao TK; Su PH; Lai HC
    Am J Pathol; 2012 Mar; 180(3):1159-1169. PubMed ID: 22222226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells.
    Chen YJ; Zhang X; Wu ZS; Wang JJ; Lau AY; Zhu T; Lobie PE
    Cancer Lett; 2015 Sep; 365(2):182-9. PubMed ID: 26070963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.
    Ayub TH; Keyver-Paik MD; Debald M; Rostamzadeh B; Thiesler T; Schröder L; Barchet W; Abramian A; Kaiser C; Kristiansen G; Kuhn W; Kübler K
    Oncotarget; 2015 Jun; 6(18):16437-48. PubMed ID: 25999351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin.
    Chen WC; Hsu HP; Li CY; Yang YJ; Hung YH; Cho CY; Wang CY; Weng TY; Lai MD
    Int J Oncol; 2016 Nov; 49(5):1881-1889. PubMed ID: 27633757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
    Arima K; Ohmuraya M; Miyake K; Koiwa M; Uchihara T; Izumi D; Gao F; Yonemura A; Bu L; Okabe H; Imai K; Hashimoto D; Baba Y; Chikamoto A; Yamashita YI; Furukawa T; Araki K; Baba H; Ishimoto T
    Oncogene; 2019 Feb; 38(8):1211-1224. PubMed ID: 30250298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
    Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
    Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780.
    Wang M; Wu L; Wang L; Xin X
    Biochem Biophys Res Commun; 2010 Feb; 393(1):144-9. PubMed ID: 20117093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
    Nakahata K; Uehara S; Nishikawa S; Kawatsu M; Zenitani M; Oue T; Okuyama H
    PLoS One; 2015; 10(4):e0125454. PubMed ID: 25915760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
    Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
    PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for epithelial-mesenchymal transition in cancer stem-like cells derived from carcinoma cell lines of the cervix uteri.
    Lin J; Liu X; Ding D
    Int J Clin Exp Pathol; 2015; 8(1):847-55. PubMed ID: 25755785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
    Wang M; Ma X; Wang J; Wang L; Wang Y
    Int J Oncol; 2014 Apr; 44(4):1401-9. PubMed ID: 24535252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.